US$ 22.13
glp-1 receptor agonist dry eye Glucagon-Like Peptide 1 Agonists and the GLP-1/GIP Receptor Agonists and Diabetic
Description
doi: 10.1023/A:1010635131228 [DOI] [PubMed] [Google Scholar] 185

N Engl J Med 385(10):896907 Gofron KK, Wasilewski A, Magorzewicz S (2025) Effects of GLP-1 analogues and agonists on the gut microbiota: a systematic review

If the body learns to rely on an exogenous source, it could potentially stop producing it on its own, therefore when you go off the drugs it could potentially make the problem worse than when you started
However, its important to note that most studies on GLP-1 drugs for autoimmune conditions have limitations

The third type of inflammation (free-radical damage) is best reduced by the transcription factor Nrf-2, which is activated by polyphenols (12)
Even at reduced prices, pharmaceutical firms would still achieve gigantic profits far surpassing what normally results from other blockbuster medications, and lower prices would not damage innovation
